IP Library Granted Patent US 8,697,450
Granted Patent B2
US 8,697,450 · App. 13/785,655 · Granted Apr 15, 2014

Measuring levels of a metabolite

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,450
App. No.
13/785,655
Granted
Apr 15, 2014
Kind
B2
Abstract

Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.

Claims (24)

1. A method for determining an amount of a steroid metabolite in a test sample, the method comprising:

(a) providing a set of calibrator samples, each calibrator sample comprising a different amount of a first isotopically-labeled standard,

(b) providing to each calibrator sample a selected constant amount of a second isotopically labeled standard, the first and second isotopically labeled standards having distinct isotope content, wherein first and second isotopically-labeled standards are labeled steroid derivatives;

(c) subjecting the calibrator samples comprising the first and second isotopically-labeled standards to mass spectrometry to determine signal intensities corresponding to the first and second isotopically-labeled standards;

(d) generating a calibration curve based on ratios of the determined signal intensities of the first and second isotopically-labeled standards as a function of the amount of the first isotopically-labeled standard in the calibrator samples;

(e) contacting a test sample with the selected constant amount of the second isotopically-labeled standard;

(f) subjecting the test sample comprising the second isotopically-labeled standard to mass spectrometry to determine signal intensities corresponding to the second isotopically labeled standard and the steroid metabolite, and

(g) using the calibration curve and the determined signal intensities corresponding to the second isotopically labeled standard and the steroid metabolite to determine the amount of the steroid metabolite in the test sample.

2. The method of claim 1 , wherein the first isotopically-labeled standard is labeled with 2H, 13 C, 15 N, 18 O, V or a combination thereof.

3. The method of claim 2 , wherein the isotopically-labeled steroid derivative standard is testosterone (3,4- 13 C; 2,2,4,6,6-d5).

4. The method of claim 2 , wherein the isotopically-labeled steroid derivative standard is 4-androstene-3,17-dione (3,4- 13 C; 2,2,4,6,6-d5).

5. The method of claim 2 , wherein the isotopically-labeled steroid derivative standard is dehydroepiandrosterone (3,4- 13 C; 2,2,3,4,4,6-d5).

6. The method of claim 2 , wherein the isotopically-labeled steroid derivative standard is progesterone (3,4- 13 C; 2,2,5,6,6,17a,21,21,21-d9).

7. The method of claim 1 , wherein the second isotopically-labeled standard is labeled with deuterium.

8. The method of claim 1 , wherein the steroid is selected from the group consisting of: 11-deoxycortisol, 21-deoxycortisol, 17-α-hydroxyprogesterone, aldosterone, 4-androstene-3,17-dione, corticosterone, deoxycorticosterone, cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, estradiol, estriol, estrone, progesterone, 5-α-dihydrotestosterone, testosterone, pregnenolone, 17-α-hydroxypregnenolone, 5-α-androstane-3b,17b-diol, 2-hydroxyestradiol, 4-hydroxyestradiol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and very low-density lipoprotein (VLDL) cholesterol, and the first and second isotopically labeled standards are isotopically-labeled derivatives of the selected steroid.

9. The method of claim 1 , wherein the mass spectrometry comprises a technique selected from LC-MS and LC-MS/MS.

10. The method of claim 1 , wherein the test sample is a biological sample.

11. The method of claim 10 , wherein the biological sample is selected from the group consisting of blood, serum, plasma, saliva, and urine.

12. The method of claim 11 , wherein the blood is provided dried on a paper matrix.

13. The method of claim 1 , wherein first and second isotopically-labeled standards each comprise a different number of isotopic labels comprising the same isotope.

14. A kit for determining an amount of a steroid metabolite in a test sample, comprising:

an isotopically labeled steroid derivative calibrator standard, and

an isotopically labeled steroid derivative internal standard,

wherein the calibrator and internal standards have distinct isotope content.

Assignments (2)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 067006/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2013
From: CERDA, BLAS; CHERKASSKIY, ALEX
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 029940/0065 →